Transcatheter aortic valve replacement was associated with improved survival in high-risk patients with diabetes and aortic stenosis, according to new research. Mortality at one year was 18% in patients treated with TAVR, compared with 27.4% in those who had surgical aortic valve replacement. The results were presented at the European Society of Cardiology Congress.

Related Summaries